0.398
price up icon0.91%   0.0036
 
loading
Athira Pharma Inc stock is traded at $0.398, with a volume of 175.10K. It is up +0.91% in the last 24 hours and down -14.81% over the past month. Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
See More
Previous Close:
$0.3944
Open:
$0.3959
24h Volume:
175.10K
Relative Volume:
0.34
Market Cap:
$15.70M
Revenue:
-
Net Income/Loss:
$-117.67M
P/E Ratio:
-0.1288
EPS:
-3.09
Net Cash Flow:
$-101.06M
1W Performance:
-0.67%
1M Performance:
-14.81%
6M Performance:
-8.32%
1Y Performance:
-87.20%
1-Day Range:
Value
$0.3801
$0.4079
1-Week Range:
Value
$0.3756
$0.413
52-Week Range:
Value
$0.2195
$3.42

Athira Pharma Inc Stock (ATHA) Company Profile

Name
Name
Athira Pharma Inc
Name
Phone
(425) 620-8501
Name
Address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Name
Employee
26
Name
Twitter
Name
Next Earnings Date
2024-12-07
Name
Latest SEC Filings
Name
ATHA's Discussions on Twitter

Compare ATHA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ATHA
Athira Pharma Inc
0.398 15.50M 0 -117.67M -101.06M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-19-24 Downgrade Mizuho Outperform → Neutral
Sep-04-24 Downgrade BTIG Research Buy → Neutral
Sep-04-24 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-04-24 Downgrade Rodman & Renshaw Buy → Neutral
Aug-19-24 Initiated Rodman & Renshaw Buy
Oct-17-22 Upgrade JMP Securities Mkt Perform → Mkt Outperform
Jul-07-22 Initiated Mizuho Buy
Jun-23-22 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-23-22 Downgrade Jefferies Buy → Hold
Jun-23-22 Downgrade Stifel Buy → Hold
May-10-22 Initiated BTIG Research Buy
Apr-21-22 Initiated Berenberg Buy
Dec-15-21 Initiated Goldman Neutral
Oct-13-20 Initiated Goldman Buy
Oct-13-20 Initiated JMP Securities Mkt Outperform
Oct-13-20 Initiated Jefferies Buy
Oct-13-20 Initiated Stifel Buy
View All

Athira Pharma Inc Stock (ATHA) Latest News

pulisher
Aug 20, 2025

Athira Pharma Inc. Testing Reversal Zone on Weekly Chart2025 Bull vs Bear & Intraday High Probability Alerts - thegnnews.com

Aug 20, 2025
pulisher
Aug 20, 2025

Applying Elliott Wave Theory to Athira Pharma Inc.Earnings Overview Summary & Consistent Return Strategy Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Has Athira Pharma Inc. found a price floorJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What moving averages say about Athira Pharma Inc.Market Sentiment Report & Entry Point Confirmation Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Athira Pharma Inc. a candidate for recovery playPortfolio Profit Report & Low Risk Profit Maximizing Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What does recent volatility data suggest for Athira Pharma Inc.CPI Data & Long-Term Growth Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Athira Pharma Reports Reduced Losses Amid Financial Challenges - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Momentum Screeners Rank Athira Pharma Inc. in Top 5 Today2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to build a dashboard for Athira Pharma Inc. stock2025 Price Targets & AI Driven Stock Movement Reports - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Price momentum metrics for Athira Pharma Inc. explainedJuly 2025 Summary & Precise Trade Entry Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Ichimoku Cloud Indicates Uncertainty Around Athira Pharma Inc.2025 Stock Rankings & Weekly Top Performers Watchlists - beatles.ru

Aug 19, 2025
pulisher
Aug 19, 2025

Can momentum traders help lift Athira Pharma Inc.Quarterly Earnings Report & Entry and Exit Point Strategies - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Sentiment analysis tools applied to Athira Pharma Inc.July 2025 Market Mood & Safe Swing Trade Setups - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is Athira Pharma Inc. building a consolidation baseEarnings Trend Report & High Conviction Investment Ideas - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Elliott Wave Theory Predicts Pullback in Athira Pharma Inc.2025 Top Gainers & Safe Capital Growth Tips - beatles.ru

Aug 18, 2025
pulisher
Aug 18, 2025

Investors Can Still File Late Claims in Athira Pharma Settlement — Here’s How to Get Your Share - TradingView

Aug 18, 2025
pulisher
Aug 17, 2025

Will Athira Pharma Inc. rebound enough to break evenJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Exit strategy if you’re trapped in Athira Pharma Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Can machine learning forecast Athira Pharma Inc. recoveryMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Athira Pharma Inc. Earnings Report Breakdown: What Investors Should KnowTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Will Athira Pharma Inc. benefit from AI trendsQuarterly Market Summary & Momentum Based Trading Ideas - classian.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Athira Pharma Inc. stock prediction for this week2025 Market WrapUp & Risk Controlled Daily Plans - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

What is the cash position of Athira Pharma Inc.Market Activity Summary & Fast Moving Trade Plans - kangso.co.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Will Athira Pharma Inc. face regulatory challenges2025 Momentum Check & Reliable Breakout Stock Forecasts - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Traders Consider Averaging Down in Athira Pharma Inc.2025 AllTime Highs & Weekly Hot Stock Watchlists - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 14, 2025

Athira Pharma presents results from Phase 1 trial of ATH-1105 at ALS Nexus - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

Athira Pharma shares rise 2.01% after-hours after presenting positive Phase 1 trial results for ATH-1105. - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

How to monitor Athira Pharma Inc. with trend dashboardsPortfolio Gains Summary & Technical Confirmation Trade Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Reversal Confirmed Athira Pharma Inc. Stock Rallies Above MAJuly 2025 Fed Impact & Weekly Watchlist of Top Performers - classian.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Athira Pharma Inc. At Decision Level — Rebound or ResistancePortfolio Value Summary & Low Risk Profit Maximizing Plans - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Athira Pharma Inc. Tests 50 Day MA After Sharp DeclineJuly 2025 Setups & High Accuracy Trade Signal Alerts - metrotimes.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025 - GlobeNewswire

Aug 14, 2025
pulisher
Aug 14, 2025

Athira Pharma reports positive Phase 1 results for ALS drug candidate - Investing.com Nigeria

Aug 14, 2025
pulisher
Aug 14, 2025

Novel Oral ALS Drug Candidate ATH-1105 Demonstrates Favorable Safety Profile in Early Trial - Stock Titan

Aug 14, 2025
pulisher
Aug 14, 2025

Are Bears Losing Grip on Athira Pharma Inc.Portfolio Value Summary & Verified Chart Pattern Trade Signals - classian.co.kr

Aug 14, 2025

Athira Pharma Inc Stock (ATHA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Athira Pharma Inc Stock (ATHA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER
Jul 01 '25
Sale
0.29
8,526
2,502
168,901
Litton Mark James
President and CEO
Jun 30 '25
Option Exercise
0.00
108,334
0
350,925
Litton Mark James
President and CEO
Jul 01 '25
Sale
0.29
25,123
7,374
325,802
San Martin Javier
CHIEF MEDICAL OFFICER
Jun 30 '25
Option Exercise
0.00
46,666
0
82,507
San Martin Javier
CHIEF MEDICAL OFFICER
Jul 01 '25
Sale
0.29
10,842
3,182
71,665
Worthington Mark
General Counsel and CCO
Jun 30 '25
Option Exercise
0.00
36,666
0
120,401
Worthington Mark
General Counsel and CCO
Jul 01 '25
Sale
0.29
8,526
2,502
111,875
Renninger Robert
SVP, Finance and Accounting
Jun 30 '25
Option Exercise
0.00
12,359
0
112,083
Renninger Robert
SVP, Finance and Accounting
Jul 01 '25
Sale
0.29
2,897
850
109,186
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):